Filing Details
- Accession Number:
- 0001610618-21-000106
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-11-15 18:38:04
- Reporting Period:
- 2021-11-12
- Accepted Time:
- 2021-11-15 18:38:04
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1610618 | Cidara Therapeutics Inc. | CDTX | Biological Products, (No Disgnostic Substances) (2836) | 461537286 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1787403 | Preetam Shah | 6310 Nancy Ridge Drive Suite 101 San Diego CA 92121 | Cfo & Cbo | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2021-11-12 | 20,000 | $1.54 | 20,000 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Billionaire Hedge Funds
